Cargando…
Interferon Gamma Targeted Therapy: Is It Justified in Primary Sjögren’s Syndrome?
Background: The pathomechanism of primary Sjögren syndrome (pSS) is multifactorial. Many cytokines take part in this process, including interferon. The study aimed to quantify certain cytokines involved in the pathomechanism of primary Sjögren syndrome (IL2, IL5, IL6, IL10, IL13, TNFα, IFNγ) and det...
Autores principales: | Sebastian, Agata, Madej, Marta, Gajdanowicz, Paweł, Sebastian, Maciej, Łuczak, Anna, Zemelka-Wiącek, Magdalena, Jutel, Marek, Wiland, Piotr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504735/ https://www.ncbi.nlm.nih.gov/pubmed/36143051 http://dx.doi.org/10.3390/jcm11185405 |
Ejemplares similares
-
The Clinical and Immunological Activity Depending on the Presence of Interferon γ in Primary Sjögren’s Syndrome—A Pilot Study
por: Sebastian, Agata, et al.
Publicado: (2021) -
Assessment of autoantibodies in paediatric population with primary immunodeficiencies: a pilot study
por: Pieniawska-Śmiech, Karolina, et al.
Publicado: (2023) -
Serum Allergen-Specific IgE among Pediatric Patients with Primary Immunodeficiency
por: Pieniawska-Śmiech, Karolina, et al.
Publicado: (2022) -
Is it possible to not perform salivary gland biopsy in targeted patients according to unstimulated salivary flow results in patients with suspected Sjögren's syndrome?
por: Sebastian, Agata, et al.
Publicado: (2021) -
Visual Evoked Potentials as Potential Biomarkers of Visual Function in Patients with Primary Sjögren’s Syndrome
por: Dziadkowiak, Edyta, et al.
Publicado: (2021)